Project: dissection
547 significantly associated models · 134 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 68059764 | 70857131 | 26 | 2 | 5.2e-09 | 7.1e-09 | 1.00 | 100 | Rdh13 Lilrb3 |
2 | 1 | 71391635 | 74334045 | 11 | 3 | 1.2e-08 | 1.3e-09 | 1.00 | 100 | Zscan18 AABR07002065.2 Zfp551 |
3 | 1 | 85224151 | 86976633 | 4 | 1 | 8.7e-08 | 1.5e-07 | 1.00 | 100 | Dmkn |
4 | 2 | 34186973 | 36646696 | 7 | 1 | 1.5e-07 | 9.4e-08 | 1.00 | 100 | Srek1 |
5 | 2 | 38950142 | 40339724 | 1 | 1 | 2.6e-07 | 8.0e-08 | 1.00 | 100 | Ercc8 |
6 | 2 | 43366934 | 44763574 | 1 | 1 | 3.3e-08 | 1.0e-02 | 0.77 | 99 | Il6st |
7 | 6 | 130177816 | 132888501 | 22 | 1 | 1.1e-09 | 1.0e-08 | 1.00 | 100 | Cdca4 |
8 | 7 | 27898185 | 30904027 | 4 | 2 | 8.9e-12 | 3.4e-13 | 0.00 | -4102 | Socs2 Nudt4 |
9 | 10 | 79659766 | 83433454 | 27 | 2 | 1.3e-10 | 1.1e-10 | 0.53 | 99 | Mrpl45 Skap1 |
10 | 12 | 27006 | 7325669 | 29 | 8 | 3.9e-12 | 4.0e-12 | 1.00 | 100 | Rxfp2 Evi5l Cers4 N4bp2l2 Pex11g Pet100 Zfp958 NA |
11 | 17 | 83844224 | 85459876 | 2 | 1 | 1.7e-07 | 1.6e-07 | 0.15 | 92 | Gad2 |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 15 | 0.707 | 3.0 |
Adipose | alternative TSS | 6 | 0.372 | 2.9 |
Adipose | gene expression | 27 | 0.325 | 2.7 |
Adipose | isoform ratio | 8 | 0.283 | 2.7 |
Adipose | intron excision ratio | 10 | 0.343 | 2.9 |
Adipose | mRNA stability | 11 | 0.319 | 2.7 |
BLA | alternative polyA | 2 | 0.167 | 2.7 |
BLA | alternative TSS | 1 | 0.119 | 2.8 |
BLA | gene expression | 24 | 0.396 | 2.8 |
BLA | isoform ratio | 4 | 0.227 | 3.0 |
BLA | intron excision ratio | 15 | 0.503 | 3.0 |
BLA | mRNA stability | 17 | 0.840 | 2.9 |
Brain | alternative polyA | 0 | 0.000 | 2.8 |
Brain | alternative TSS | 10 | 0.582 | 2.9 |
Brain | gene expression | 37 | 0.409 | 2.7 |
Brain | isoform ratio | 2 | 0.063 | 2.8 |
Brain | intron excision ratio | 32 | 0.592 | 3.0 |
Brain | mRNA stability | 15 | 0.344 | 2.6 |
Eye | alternative polyA | 0 | 0.000 | 3.0 |
Eye | alternative TSS | 0 | 0.000 | 2.9 |
Eye | gene expression | 4 | 0.356 | 2.8 |
Eye | isoform ratio | 0 | 0.000 | 2.9 |
Eye | intron excision ratio | 7 | 1.144 | 3.0 |
Eye | mRNA stability | 1 | 0.431 | 2.9 |
IL | alternative polyA | 0 | 0.000 | 3.1 |
IL | alternative TSS | 2 | 0.692 | 3.0 |
IL | gene expression | 10 | 0.274 | 2.7 |
IL | isoform ratio | 0 | 0.000 | 3.4 |
IL | intron excision ratio | 6 | 0.622 | 2.7 |
IL | mRNA stability | 8 | 0.721 | 2.7 |
LHb | alternative polyA | 0 | 0.000 | 3.0 |
LHb | alternative TSS | 1 | 0.287 | 2.7 |
LHb | gene expression | 11 | 0.343 | 2.8 |
LHb | isoform ratio | 0 | 0.000 | 3.1 |
LHb | intron excision ratio | 3 | 0.292 | 2.9 |
LHb | mRNA stability | 4 | 0.387 | 2.8 |
Liver | alternative polyA | 3 | 0.200 | 2.9 |
Liver | alternative TSS | 2 | 0.132 | 2.6 |
Liver | gene expression | 29 | 0.403 | 2.7 |
Liver | isoform ratio | 11 | 0.460 | 2.7 |
Liver | intron excision ratio | 21 | 0.480 | 2.8 |
Liver | mRNA stability | 8 | 0.326 | 2.7 |
NAcc | alternative polyA | 0 | 0.000 | 3.0 |
NAcc | alternative TSS | 0 | 0.000 | 2.8 |
NAcc | gene expression | 13 | 0.396 | 2.8 |
NAcc | isoform ratio | 0 | 0.000 | 2.9 |
NAcc | intron excision ratio | 4 | 0.419 | 2.9 |
NAcc | mRNA stability | 5 | 0.462 | 2.8 |
NAcc2 | alternative polyA | 3 | 0.271 | 2.7 |
NAcc2 | alternative TSS | 0 | 0.000 | 2.9 |
NAcc2 | gene expression | 26 | 0.487 | 2.8 |
NAcc2 | isoform ratio | 1 | 0.065 | 2.8 |
NAcc2 | intron excision ratio | 13 | 0.491 | 2.9 |
NAcc2 | mRNA stability | 5 | 0.280 | 2.7 |
OFC | alternative polyA | 0 | 0.000 | 2.6 |
OFC | alternative TSS | 1 | 0.313 | 2.5 |
OFC | gene expression | 10 | 0.270 | 2.8 |
OFC | isoform ratio | 3 | 0.368 | 3.2 |
OFC | intron excision ratio | 6 | 0.597 | 3.1 |
OFC | mRNA stability | 5 | 0.463 | 2.8 |
PL | alternative polyA | 0 | 0.000 | 3.0 |
PL | alternative TSS | 0 | 0.000 | 2.2 |
PL | gene expression | 11 | 0.296 | 2.8 |
PL | isoform ratio | 0 | 0.000 | 3.0 |
PL | intron excision ratio | 5 | 0.480 | 3.1 |
PL | mRNA stability | 4 | 0.348 | 2.7 |
PL2 | alternative polyA | 5 | 0.398 | 2.9 |
PL2 | alternative TSS | 1 | 0.106 | 3.2 |
PL2 | gene expression | 26 | 0.407 | 2.8 |
PL2 | isoform ratio | 6 | 0.325 | 2.9 |
PL2 | intron excision ratio | 14 | 0.444 | 3.1 |
PL2 | mRNA stability | 13 | 0.533 | 2.7 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.